|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
|
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash and cash equivalents | ||||||
| Restricted cash | ||||||
| Accounts receivable | ||||||
| Prepaid expenses | ||||||
| Current tax receivable | ||||||
| Other assets | ||||||
| Receivables, net | ||||||
| Investments in receivables, net | ||||||
| Credit card receivables | ||||||
| Property, plant and equipment, net | ||||||
| Other intangible assets, net | ||||||
| Goodwill | ||||||
| Total Assets | ||||||
| Liabilities and Stockholder's Equity | ||||||
| Liabilities | ||||||
| Accounts payable and accrued expenses | ||||||
| Other liabilities | ||||||
| Current tax liabilities | ||||||
| Deferred tax liabilities | ||||||
| Notes payable, net | ||||||
| Total Liabilities | ||||||
| Stockholders' Equity | ||||||
| Common Stock par value $0.0001 per share; 330,000,000 shares authorized as of September 30, 2026 and December 31, 2025 and 57,454,589 and 58,298,923 shares issued and outstanding as of September 30, 2026 and December 31, 2025 | ||||||
| Additional paid-in capital | ||||||
| Retained earnings | ||||||
| Accumulated other comprehensive income (loss) | ||||||
| Total stockholders' equity | ||||||
| Total Liabilities and Stockholders' Equity |
Loading...